OwnershipPublicly listed · Nasdaq: BIOASEC EDGAR company record and tickers file (Nasdaq: BIOA) · checked Oct 28, 2026
Commercial developmentNot yet assessedWe only state a stage once a source supports it. Having a product on sale does not show it works or makes money.
Investment accessVerified public listingListed as Nasdaq: BIOA, per the SEC's company tickers file. A listing means shares trade publicly; it says nothing about whether they are a good investment.Source · checked Oct 28, 2026
Evidence is labelled on each development below (company-reported, regulatory filing or government record), not on the company as a whole. Next scheduled recheck: Nov 27, 2026.
3developments published
—US federal obligations on record
1private-offering notices since 2019
Aug 5, 2026latest development
Timeline
- Aug 5, 2026 · Reported results
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
Company-reported - Jun 10, 2026 · Shareholder vote
BioAge Labs reports results of a shareholder vote (Form 8-K, Item 5.07)
Regulatory filing - May 8, 2026 · Reported results
BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates
Company-reported
Profile
- Legal name
- BioAge Labs, Inc.
- Listing
- Nasdaq BIOA
- SEC filer
- CIK 0001709941 ↗
- SEC industry code
- Pharmaceutical Preparations
- Incorporated
- DE
- Coverage
- Filings + federal awards
Mix of developments
Watch BioAge Labs
Anything new from BioAge Labs lands in your digest, with the source beside it. Following is about information, never an investment action. Up to 10 companies or frontiers on Pro, $49/month.
Follow this companyPreview a sample digestPrivate offerings reported to the SEC (Form D)
A Form D is a notice a company files after selling securities without a public registration. Amount sold is cumulative for that offering as reported by the company; an amendment (D/A) updates an earlier notice, so rows are not added together. None of these is a valuation or an open offer.
| Filed | Form | Amount sold | Offering size | First sale | Investors | Exemption | Record |
|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | D | $194 million | $194 million | Feb 1, 2024 | 32 | Rule 506(b) | SEC ↗ |